2024-11-30 05:36:21
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC
Corporate/ 2023-07-24
CStone announces first patient enrollmen...

Commencement of the first-in-human clinical trial of CS5001 marks another key milestone for CStone\'s Pipeline 2.0

Change of Composition of the Telix Board of Directors
Corporate/ 2023-07-24
Change of Composition of the Telix Board...

Non-Executive Director Oliver Buck to retire at the Annual General Meeting Tiffany Olson,experienced U.S.-based pharma executive appointed a...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release